Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The eye is a complex organ with a unique physiology and anatomy. Eye drops and lubricants are the liquid in the forms of water and oil solutions, emulsions, or suspensions of active ingredients. These forms are sterile and isotonic. The optimum pH of eye drops is equals to tear fluid and is about 7.4. They are often used to treat eye pain, discomfort and infection of disease. Many pharmaceutical companies produce lots of ophthalmic dosage forms as it has been one of the most important and widely used technology for dozens of years. The eye drops constitute approximately 90 % of the ophthalmic dosage forms. The growth of global eye drops and lubricants market is expected to have major growth in upcoming years due to prevalence of ophthalmic disorders worldwide and change in the demographics across the globe
The key factor for the growth of eye drops and lubricants market is growing cases of ophthalmic disorders is majorly observed in number of old age population and is significantly increasing the cases of age related eye disorders such as macular degeneration, cataract, glaucoma and other diseases across the globe is driving the growth of global eye drops and lubricants market. Beside rise in research and development activities has primary purpose to achieve the required drug concentration in the place of absorption and sustaining it for appropriately long time, which in turn contributes to smaller application frequency
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the eye drops and lubricants market. In addition, complete analysis of changes on the eye drops and lubricants market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the eye drops and lubricants market was moderate as patient’s inflow for eye disorder has decreased due to safety concern and COVID-19 virus has ultimately affected the growth of eye drops and lubricants market
The eye drops and lubricants market is segmented based on by type, by application, by end users, by distribution channel and geography
The eye drops and lubricants are available in different types including antibiotics, hormones and artificial tears
Artificial tears leads in the global eye drops and lubricants market accounting the major revenue. The growth is attributed to increasing demand for the product due to surge in dry eye syndrome across the world. In addition, artificial tears increases eye lubrication by mimicking characteristics of the tear film which is further fueling the segment growth. Moreover, easy availability and accessibility of lubricating eye drops fuels the market growth. Whereas hormone is anticipated to witness the highest growth due to increasing incidence of dry eye in postmenopausal women thereby propelling the growth of global eye drops and lubricants market
Eye drops and lubricants has its application in eye diseases, eye care
Eye Diseases is further bifurcated to conjunctivitis, dry eye, glaucoma, refractive errors, others. Eye disease leads in the global eye drops and lubricants market due to growing eye disorders like macular degeneration, glaucoma and diabetic retinopathy in geriatric population. Since vision loss among the elderly is a major health care problem and approximately one person in three has some form of vision-reducing eye disease by the age of 65 thereby fueling the eye drops and lubricants market growth. On the other hand eye care is expected to be the fastest growing owing to the rising number of cataract and other eye related surgeries that require the use of eye drops after surgeries which is ultimately fueling the growth of eye drops and lubricants market.
The eye drops and lubricants has major end use in hospitals, homecare, specialty clinics
Hospital and Specialty clinics is expected to have major end use owing to increasing patient inflow for eye disorders and presence of specialist ophthalmologists prescribing certain medication eye drops and lubricants which is further boosting the segment growth.
The distribution of eye drops and lubricants are done via various channel like hospital pharmacy, online pharmacy, retail pharmacy
Retail pharmacy is expected to have major distribution of eye drops and lubricants as these supply prescription and non-prescription medication and provide general healthcare advice to consumer enquiries. Whereas hospital pharmacy is anticipated to have significant growth during the forecast period.
Geographically the global eye drops and lubricants market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
North America is expected to witness the highest growth accounting significant share attributed to increasing prevalence of ophthalmic disorders. In addition increasing number of FDA approval drugs is fueling the regional growth. Whereas Europe is likely to be the second largest region for the growth of global eye drops and lubricants market owing to presence of the key marketed players and increases focuses on the ophthalmic disorders. However Asia Pacific is projected to have growth at the highest pace due to rapid development in healthcare infrastructure, growing incidence of ophthalmic disorders, and rise in government initiatives and specialist communities is propelling the regional growth.
The key players in eye drops and lubricants market are Akorn Consumer Health (TheraTears), Allergan Plc, Johnson & Johnson, Prestige Consumer Healthcare, Inc, Bausch Health, Novartis International AG (Alcon Inc.), Pfizer Inc., Sager Pharma Kft, Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated), Jawa Pharmaceuticals Pvt. Ltd., ROHTO Pharmaceutical Co., Ltd., Similasan Corporation USA, Hanuchem Laboratories, Oculent Healthcare, Maya Biotech and Neiss Labs Ltd. among others.
March 2020: Alcon had Introduced Systane hydration preservative-free lubricant eye drops with hydroboost technology for sensitive, dry eyes. Systane Hydration Pf Lubricant Eye Drops is a new preservative free option for dry eye sufferers with sensitive eyes and those in need of long-lasting relief. It is used as a protectant against further irritation and to relieve dryness for the eye.
July 2018: Allergan had Launched New Refresh Repair Lubricant Eye Drops. The first and only artificial tear in the U.S. formulated with carboxymethylcellulose (CMC), hyaluronic acid (HA, an inactive ingredient), and osmoprotectants, Refresh Repair is the latest addition to the Refresh portfolio. Refresh Repair tears are designed to repair and protect the eyes from the harmful effects of dry eye and improve clarity of vision.
The report analyses the global eye drops and lubricants market based on by type, by application, by end users, by distribution channel and geography. The eye drops and lubricants are available in different types including antibiotics, hormones and artificial tears. Eye drops and lubricants has its application in eye diseases, eye care. The eye drops and lubricants has major end use in hospitals, homecare, specialty clinics. The distribution of eye drops and lubricants are done via various channel like hospital pharmacy, online pharmacy, retail pharmacy. Geographically the global eye drops and lubricants market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
The key players in eye drops and lubricants market are Akorn Consumer Health (TheraTears), Allergan Plc, Johnson & Johnson, Prestige Consumer Healthcare, Inc, Bausch Health, Novartis International AG (Alcon Inc.), Pfizer Inc., Sager Pharma Kft, Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated), Jawa Pharmaceuticals Pvt. Ltd., ROHTO Pharmaceutical Co., Ltd., Similasan Corporation USA, Hanuchem Laboratories, Oculent Healthcare, Maya Biotech and Neiss Labs Ltd. among others.
Why to buy this report:
